TMED — T. Rowe Price Health Care ETF
Data updated: 2026-05-28
TMED — T. Rowe Price Health Care ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $20.26M AUM · 0.44% expense ratio. From SEC regulatory filings.
TMED Fund Overview
TMED — T. Rowe Price Health Care ETF is a US ETF managed by T. Rowe Price Exchange-Traded Funds, Inc., categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: T. Rowe Price Exchange-Traded Funds, Inc.
- Category: United States Health Care Equity
- Assets under management: $20.26M
- Ticker: TMED
- SEC CIK: 0001795351
- SEC series ID: S000092023
- Share class ID: C000259933
TMED Holdings
Top 10 holdings of T. Rowe Price Health Care ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co. | 14.48% |
| Unitedhealth Group, Inc. | 6.54% |
| Thermo Fisher Scientific, Inc. | 4.59% |
| Gilead Sciences, Inc. | 4.14% |
| Abbott Laboratories | 3.91% |
| Danaher Corp. | 2.73% |
| Medtronic PLC | 2.24% |
| Alnylam Pharmaceuticals, Inc. | 2.06% |
| Stryker Corp. | 2.00% |
| Dyne Therapeutics, Inc. | 1.88% |
TMED Portfolio Allocation
Asset-class allocation of T. Rowe Price Health Care ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.8% |
| Cash & Equivalents | 0.6% |
TMED Performance
Total returns for TMED (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -2.5% |
TMED Costs and Fees
TMED costs about $44 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.44%
- Gross expense ratio: 0.44%
- Portfolio turnover: 44%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
TMED Cashflows
Over the 12 months to 2026-03, T. Rowe Price Health Care ETF had net inflows of $18.21M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | $1.43M |
| 2026-02 | $1.50M |
| 2026-01 | $1.49M |
| 2025-12 | $1.44M |
| 2025-11 | −$1.44M |
| 2025-10 | $1.39M |
TMED Debt Constituents
No individual debt constituents are reported in T. Rowe Price Health Care ETF's latest SEC N-PORT filing.
TMED Prospectus and SEC Filings
Official T. Rowe Price Health Care ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.